At 10:09 am; the stock was locked at the maximum 5 per cent upper circuit at Rs 603.75, a 270 per cent jump over its issue price of Rs 163 per share
The stock listed at Rs 1,150, a 17 per cent premium over to its issue price of Rs 980 per share on the BSE.
The earnings season has almost come to an end, going forward individual stocks will react to corporate developments and broader market trend
Both the stocks seem to have bottomed out and select indicators on the charts have turned favourable for these stocks, says the technical analyst from Prabhudas Lilladher
With the demand uptick in key markets, and expected easing off of the Covid-19 and semi-conductor situation globally, the company is confident that the uptrend in growth trajectory will resume
The Global Index provider, MSCI, has added Zomato in its MSCI Global Standard India Index and added Devyani International in MSCI India Domestic Small Cap Index.
At 12:10 PM, with a market-cap of Rs 1.10 trillion, Nykaa stood at 48th position in overall market-cap ranking, the BSE data showed
Till 10:34 AM, around 4.28 million equity shares representing 1.1 per cent of total equity of InterGlobe Aviation had changed hands on the BSE
Adani Transmission rallied 5% to Rs 1,995, while, Adani Total Gas was up 4 per cent to Rs 1,715 on the BSE in the intra-day trade on Friday
The stock opened at Rs 544.35, a 6% discount to its issue price of Rs 577 per share
Amaraja Batteries, Apollo Hospitals, Ashok Leyland, Bharat Forge, BPL, Glenmark Pharma, Hero MotoCorp, Vodafone Idea, National Aluminium, Reliance Capital, SpiceJet and Suzlon are some of the stocks
The derivative analyst from HDFC Securities recommends this strategy based on the following four rationales
According to the technical analyst from Anand Rathi, most technical indicators are in favour of the bullish bias for these three stocks
Further, the company's board has approved incorporation of a wholly-owned subsidiary which will leverage the growth opportunities in the "Home Textiles"
Thermax rallied 12 per cent to Rs 1,503 after it reported 183 per cent year-on-year jump in its consolidated profit after tax
Alembic Pharma said that the USFDA recently inspected the company's injectable facility (F-3) site and issued Form 483 with 10 observations
In Q2FY22, power systems segment posted PBIT of Rs 7.16 crore against loss of Rs 2.10 crore in Q2FY21.
The company said Indian operations staged a decent recovery in the quarter gone by, after the significant impact was observed in Q1FY22.
CESC, HCC, NDTV, PEL, PFC, Railtel, Bajaj Hindusthan, CESC, Godrej Consumer, Hindustan Oil, Indiabulls Housing Finance, Natco Pharma, Novartis, PNB Gilts and Sundaram Fasteners to announce Q2 results
The management said a muted sales performance accompanied with a drop in gross margins and relatively higher operating costs has led to a negative operating leverage in H1